{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:08:17Z","timestamp":1792516097522,"version":"4.5.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10147-024-02579-z","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:01:52Z","timestamp":1721023312000},"page":"1207-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia\/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan"],"prefix":"10.1007","volume":"29","author":[{"given":"Noriomi","family":"Matsumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2579_CR1","unstructured":"Pharmaceuticals and Medical Devices Agency (2024) List of approved drugs (in Japanese). https:\/\/www.pmda.go.jp\/files\/000268495.pdf Accessed on June 30, 2024"},{"key":"2579_CR2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S1470-2045(22)00541-1","volume":"23","author":"V Subbiah","year":"2022","unstructured":"Subbiah V, Wolf J, Konda B et al (2022) Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1\/2, open-label, basket trial. Lancet Oncol 23:1261\u20131273. https:\/\/doi.org\/10.1016\/S1470-2045(22)00541-1","journal-title":"Lancet Oncol"},{"key":"2579_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101952","volume":"59","author":"Y Yu","year":"2023","unstructured":"Yu Y, Zhou J, Li X et al (2023) Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b\/2 trial. EClinicalMedicine 59:101952. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101952","journal-title":"EClinicalMedicine"},{"key":"2579_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0140-6736(22)02036-0","volume":"401","author":"S Verstovsek","year":"2023","unstructured":"Verstovsek S, Gerds AT, Vannucchi AM et al (2023) Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Lancet 401:269\u2013280. https:\/\/doi.org\/10.1016\/S0140-6736(22)02036-0","journal-title":"Lancet"},{"key":"2579_CR5","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1200\/JCO.2017.73.4418","volume":"35","author":"RA Mesa","year":"2017","unstructured":"Mesa RA, Kiladjian JJ, Catalano JV et al (2017) SIMPLIFY-1: a phase III randomized trial of momelotinib versus ruxolitinib in janus kinase inhibitor-na\u00efve patients with myelofibrosis. J Clin Oncol 35:3844\u20133850. https:\/\/doi.org\/10.1200\/JCO.2017.73.4418","journal-title":"J Clin Oncol"},{"key":"2579_CR6","unstructured":"Minophagen Pharmaceutical (2024) Package Insert for Bexarotene. (in Japanese) https:\/\/www.minophagen.co.jp\/Japanese\/medical\/product\/pdf\/tar_02_B-6.pdf. Accessed on June 30, 2024"},{"issue":"Supplement 1","key":"2579_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1182\/blood-2023-179304","volume":"142","author":"SM Horwitz","year":"2023","unstructured":"Horwitz SM, Izutsu K, Mehta-Shah N et al (2023) Efficacy and safety of valemetostat monotherapy in patients with relapsed or refractory peripheral T-cell lymphomas: primary results of the phase 2 VALENTINE-PTCL01 study. Blood 142(Supplement 1):302. https:\/\/doi.org\/10.1182\/blood-2023-179304","journal-title":"Blood"},{"key":"2579_CR8","unstructured":"Eli Lilly Japan (2024) Package Insert for Pirtobrutinib. (in Japanese) https:\/\/medical.lilly.com\/jp\/answers\/228207 Accessed on June 30, 2024"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02579-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02579-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T01:03:51Z","timestamp":1724720631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02579-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2579"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02579-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"15 July 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}